Effect of Bharangyadi churna in the management of Bronchial Asthma .

Effect of Bharangyadi churna in the management of Tamaka shwasa w.s.r Bronchial Asthma - A randomised double blind control clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/10/006270

Enrollment

Registered

2015-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with symptoms of Bronchial Asthma and who satisfy inclusion critriea

Interventions

Intervention1: bharangyadi churna 4 gms three times in a day oral route for 30 days: bharangi and shunthi both in equal quantity Control Intervention1: shathyadi churna 4 gms three times in a day afte

Eligibility

Inclusion criteria

Inclusion criteria: patients having pratyatma lakshana of Tamaka swasa patients with or without ongoing treatment for Bronchial Asthma

Exclusion criteria

Exclusion criteria: severe exacerbated cases of Asthma Shwasa with chronic infective conditions like pleural effusion and TB cardiac Asthma

Design outcomes

Primary

Measure	Time frame
Dyspnoea coughTimepoint: one month	—

Secondary

Measure	Time frame
swasa kruchata kasaTimepoint: one month	—

Countries

India

Contacts

Public ContactDr Ritesh kumar Lahoti

KLEU Shri BMK Ayurveda mahavidyalaya

drvghuddar@gmail.com9986697942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026